Laurus Labs Ltd
Ticker: LAURUSLABS
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
875.30
Market Cap
47250.87
Debt/Equity
0.6005
ROE %
8.220
PB
10.2663
Promoter %
27.594
Pledge %
0.741
1Y Rev Growth %
11.089
5Y Rev Growth %
14.682
NP Margin %
6.366
NP Margin 5Y Avg %
11.930
Trading Reference
1M Return %
-2.118
6M Return %
40.014
1Y Return %
81.598
% Away 52W High
7.849
% Away 52W Low
98.729
Daily Volume
781858
Investment Verdict
Risky
Score 49/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 50/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Laurus Labs Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock can break above the resistance level at ₹600 with increasing volume, there is a potential for upside. Conversely, if it falls below the support level at ₹500, it may face further downside risk.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
K
Kaynes Technology India Ltd
Kaynes Technology India Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised for new investments.
View details
F
Federal Bank Ltd
Federal Bank Ltd shows decent potential but faces challenges in profitability and valuation metrics.
View details
U
United Breweries Ltd
United Breweries Ltd shows potential for growth, but faces challenges in profitability and valuation compared to peers.
View details
P
Premier Energies Ltd
Premier Energies Ltd has potential in a growing sector, but faces challenges in execution and profitability.
View details
A
APL Apollo Tubes Ltd
APL Apollo Tubes Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
View details
G
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd shows decent fundamentals but faces challenges in profitability and market sentiment. It is a stable player in a growing sector, but caution is advised due to valuation concerns and execution risks.
View details
A
Anthem Biosciences Ltd
Anthem Biosciences Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
V
Voltas Ltd
Voltas Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
B
Balkrishna Industries Ltd
Balkrishna Industries Ltd shows a decent investment potential with strong fundamentals, but caution is advised due to valuation concerns and execution risks.
View details
H
Hexaware Technologies Ltd
Hexaware Technologies has a decent outlook with growth potential, but faces challenges in profitability and valuation metrics.
View details
T
Tata Communications Ltd
Tata Communications Ltd shows potential for growth but faces challenges in profitability and execution risks. It is a decent investment but requires careful monitoring.
View details
C
Cochin Shipyard Ltd
Cochin Shipyard Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
D
Dalmia Bharat Ltd
Dalmia Bharat Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
L
L&T Technology Services Ltd
L&T Technology Services Ltd shows decent potential with a strong focus on digital transformation, but faces challenges in profitability and valuation compared to peers.
View details
H
Housing and Urban Development Corporation Ltd
The stock presents a decent investment opportunity but comes with notable risks and challenges.
View details
3
360 One Wam Ltd
360 One Wam Ltd shows a decent investment potential with consistent growth and a strong business model, but some risks in execution and valuation metrics should be considered.
View details
Business Overview
Laurus Labs Ltd is a leading Indian pharmaceutical and biotechnology company focused on providing high-quality, affordable medicines. Catering to both domestic and international markets, Laurus Labs specializes in active pharmaceutical ingredients (APIs) and formulations, making it a key player in the healthcare sector. The company is committed to innovation and sustainability, ensuring access to essential medicines for patients worldwide. With a robust pipeline and strategic partnerships, Laurus Labs is well-positioned for growth, making it a compelling choice for investors looking to support the future of healthcare.
- Leading player in pharmaceuticals and biotechnology
- Focus on affordable and high-quality medicines
- Strong presence in both domestic and international markets
- Commitment to innovation and sustainability
- Robust pipeline and strategic partnerships
- Supports access to essential medicines globally
Investment Thesis
Laurus Labs Ltd stands out due to its strong promoter credibility and robust growth in digital services. The company's attractive valuation compared to peers presents a compelling investment opportunity, positioning it well for future growth in the pharmaceutical sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services, tapping into a lucrative market.
- Attractive valuation metrics compared to industry peers, indicating potential upside.
- Diversified product portfolio reduces risk and enhances revenue stability.
- Strategic partnerships and R&D investments position Laurus for sustained growth.
Opportunity vs Risk
Opportunities
- Strong growth in pharma sector
- Expanding international markets
- Robust R&D pipeline
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in generics
- Currency fluctuations affecting profits
- Dependence on few key products
Peer Perspective
Laurus Labs Ltd trades at a discount to peers like Dr. Reddy's and Aurobindo Pharma, reflecting concerns over margin stability; a consistent improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Laurus Labs Ltd is well-positioned for growth in the pharmaceutical sector, provided it maintains strong execution and cost control. Continued innovation and strategic partnerships could enhance its market presence and profitability.
AI FAQs for Retail Users
- Q: What does Laurus Labs Ltd do?A: Laurus Labs Ltd is a pharmaceutical company focusing on APIs, formulations, and contract manufacturing.
- Q: Is Laurus Labs Ltd a good investment?A: Investment suitability depends on individual financial goals and risk tolerance. Research is recommended.
- Q: What are the main markets for Laurus Labs?A: Laurus Labs primarily operates in India, the US, and Europe.
- Q: How has Laurus Labs performed recently?A: Recent performance can be checked through financial news and stock analysis platforms.
- Q: What are the risks associated with investing in Laurus Labs?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Laurus Labs Ltd • Updated: 2025-09-17 03:18:59
-
10BusinessHighPharmaceutical sector with strong growth potential, but competition is increasing.
-
10GrowthHighConsistent revenue growth over the past few years, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF has shown volatility.
-
8ValuationHighP/E and P/B ratios are higher than industry averages, indicating potential overvaluation.
-
7BalanceHighModerate debt levels, but liquidity ratios are satisfactory.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodStrong product pipeline, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is mixed, with recent price action showing volatility.
Final Score & Verdict
Score 68 / 100
• Decent
Laurus Labs Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 80/100
- Profitability: 70/100
- Governance: 65/100
- Market Confidence: 72/100